If you are having trouble viewing this email please go to http://www.biocompsystems.com/newsletters/Bits/v3n8.html to view it in your browser. To ensure receipt of our emails, please add profit@biocompsystems.com to your Address Book or add to your email server white list. Thank you.

News Items

BioComp Profit 8.0.3 Update
BioComp Profit 8.0.3 is now available. Profit 8 users should please head to the forums for release information and to download.

BioComp Profit 8 Temporary Reduction
For a limited time, upgrade to Profit 8, or get a new license, for a 20% reduction off the normal list price.

Product Info >>
Order >>
(Prices shown do reflect the reduction)

These prices will be available only until November 8th, 11:59 PM.

P.S. If you order Profit and Dakota on the same order, either as a first purchase and/or an upgrade, we'll shave off another 10% from your total.

P.S.S: Preferred Customer Program applies, as always...

Commentary

Riding Out the Market Volatility? Sharpen Your Tools
It's been tough, rough and very risky to trade lately. Sure, you could make a lot of money if you were to put your fiscal toe in the water just at the right place, just at the right time, but more likely it would get bit off by the sharks in the 70-90 VIX whirlpool. Instead, most traders have smartly cut their positions or are out, waiting for the storm to pass. What do you do while the hurricane rages, besides than twiddle your thumbs and lick any wounds? Use this time to your advantage... Sharpen your tools and build your skills.

Combined with the offer above, this is an excellent time to upgrade or pick up a new tool, such as Dakota or Profit 8 (or both) and learn how to use them effectively so when the markets settle down into a rational range, you are ready to jump in and draw some profits.

 

Combining the Horsepower of BioComp Dakota and Profit
People are combining Dakota with Profit to create some very nice equity curves. The chart below is from Profit 8, as posted by a customer in our forums. The top panel is price, middle panel is the buy/sell/out signal and the lower panel is the hypothetical gains in your account. In this case, a set of signals created by Dakota are imported into and act as inputs to a Profit 8 system. Profit 8 then "fuses together" the signals into a final set of buy/sell signals.

 

What is the Risk of Hyper-Inflation?
Hyper-inflation is run-away inflation. You can read about it here at Wikipedia. It's real. It's more common than you may think. There has been at least a dozen cases in this decade and right now in Zimbabwe, at the end of October 2008, inflation was speculated to be approaching 1,000,000,000%. But it doesn't just just happen smaller countries, but historically also Germany, Japan, Israel, China and TWICE already in the USA. Per Wikipedia; "The main cause of hyperinflation is a massive and rapid increase in the amount of money, which is not supported by growth in the output of goods and services." With all the loans to the banks, 100's of billions in bail-out money, the sum of which I'm not sure anyone knows (many trillions of US$), and the Fed loaning money below the current inflation rate, what is the risk of hyper-inflation in the USA? And with the interconnectedness of economies now, globally?

Email me at cmcook@biocompsystems.com, I'll tablulate the responses and report them back in the next issue.

Thanks!

Items of Interest

Dakota Videos
See how Dakota works and how to use it.
GO >>
Profit Videos
Watch a Quick Tour (Windows Media Video)
GO >>
Free Add-In Source Code
When you license Dakota you get access to source code for bots, stops and "Equity Engines" in VB6, C# and VB 2008 (.NET)!
Dakota Home ››
Profit Home ››

 

Customer Quotes
"One thing you can use for future reference is that we did some comparative time series work in [competitor] and BioComp to compare the results and BioComp produced better models every time."
- Rochester, New York, USA Oct 22, 2008

"I have just started to do some work with Profit 8 so I am still learning. However, I am getting some great results! Profit 8 is a modeling powerhouse."

"There have been times when I thought Dakota would completely supersede Profit. However, with the ingenious Carl Cook at the helm Profit is back with a vengeance!"
- Sydney, Australia, Oct 20, 2008

This newsletter is brought to you by BioComp Systems, Inc. Please forward it to anyone who might be interested. They can also subscribe at: http://www.biocompsystems.com/cgi-bin/mojo.cgi?f=s&l=Profit

These documents are provided for informational purposes only. The information contained in this document represents the current view of BioComp Systems on the material discussed as of the date of publication and may contain errors and omissions. Materials written should not be interpreted to be a commitment on the part of BioComp and BioComp cannot guarantee the accuracy of any information presented after the date of publication. INFORMATION PROVIDED IN THIS DOCUMENT IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND FRE'EDOM FROM INFRINGEMENT. Statements of equity performance are hypothetical unless otherwise stated. Hypothetical results have not been substantiated by records of actual trading and have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to those mentioned. The user assumes the entire risk as to the accuracy and the use of this document. This document may be copied and distributed subject to the following conditions: 1) The entire document must be copied without modification; 2) All copies must contain BioComp's copyright notice and any other notices provided therein; and 3) This document may not be distributed for profit. All trademarks acknowledged. (C) Copyright BioComp Systems, Inc. 2008.